ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe.

ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe.

Item
http://www.wikidata.org/entity/Q38908352
Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars.Opportunities to significantly reduce expenditure associated with cancer drugs.The high price of anticancer drugs: origins, implications, barriers, solutions.ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of anti-neoplastic medicines in countries outside of Europe.Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan.Metastatic anorectal melanomas - An exploratory retrospective analysis on the benefits of systemic therapy versus best supportive care in a resource-limited setting from India.Back to the 'essence' of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines.Global cancer control: responding to the growing burden, rising costs and inequalities in access.Availability and affordability of biologic versus non-biologic anticancer medicines: a cross-sectional study in Punjab, Pakistan.Consent for participating in clinical trials - Is it really informed?
P2860

ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe.

Item
http://www.wikidata.org/entity/Q38908352
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
ESMO European Consortium Study ...... eoplastic medicines in Europe.
@en
type
label
ESMO European Consortium Study ...... eoplastic medicines in Europe.
@en
prefLabel
ESMO European Consortium Study ...... eoplastic medicines in Europe.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
ESMO European Consortium Study ...... neoplastic medicines in Europe
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698